PubRank

Ian N Hampson

Author PubWeight™ 16.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci 2003 1.30
2 Therapy of human papillomavirus-related disease. Vaccine 2012 1.11
3 Analysis of factors contributing to the low survival of cervical cancer patients undergoing radiotherapy in Kenya. PLoS One 2013 1.11
4 HIV Infection Alters the Spectrum of HPV Subtypes Found in Cervical Smears and Carcinomas from Kenyan Women. Open Virol J 2013 0.99
5 Hypoxia increases heparanase-dependent tumor cell invasion, which can be inhibited by antiheparanase antibodies. Cancer Res 2004 0.96
6 Specific HIV protease inhibitors inhibit the ability of HPV16 E6 to degrade p53 and selectively kill E6-dependent cervical carcinoma cells in vitro. Antivir Ther 2006 0.91
7 Combining metabolic fingerprinting and footprinting to understand the phenotypic response of HPV16 E6 expressing cervical carcinoma cells exposed to the HIV anti-viral drug lopinavir. Analyst 2010 0.90
8 Human papillomavirus 16 E6 increases the radiosensitivity of p53-mutated cervical cancer cells, associated with up-regulation of aurora A. Int J Radiat Biol 2010 0.85
9 Murine serpin 2A is a redox-sensitive intracellular protein. Biochem J 2003 0.83
10 Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease. Antivir Ther 2009 0.82
11 Cidofovir induces an increase in levels of low-risk and high-risk HPV E6. Head Neck 2009 0.81
12 Lopinavir shows greater specificity than zinc finger ejecting compounds as a potential treatment for human papillomavirus-related lesions. Antiviral Res 2011 0.80
13 Effects of cidofovir on a novel cell-based test system for recurrent respiratory papillomatosis. Head Neck 2007 0.79
14 Lopinavir up-regulates expression of the antiviral protein ribonuclease L in human papillomavirus-positive cervical carcinoma cells. Antivir Ther 2011 0.79
15 Raman chemical mapping reveals site of action of HIV protease inhibitors in HPV16 E6 expressing cervical carcinoma cells. Anal Bioanal Chem 2010 0.79
16 No biological evidence of XMRV infection in cervical smears from HIV/ HPV positive and negative Kenyan women. PLoS One 2012 0.77
17 A metabolomics investigation into the effects of HIV protease inhibitors on HPV16 E6 expressing cervical carcinoma cells. Mol Biosyst 2014 0.77
18 Increased prevalence of JC polyomavirus in cervical carcinomas from women infected with HIV. J Med Virol 2013 0.77
19 Photodynamic therapy of lower genital tract neoplasia. Gynecol Oncol 2002 0.75
20 Targeting activated Rho proteins: a new approach for treatment of HPV and other virus-related cancers? Expert Rev Anticancer Ther 2011 0.75
21 Using HIV drugs to target human papilloma virus. Expert Rev Anti Infect Ther 2014 0.75